Matches in Wikidata for { <http://www.wikidata.org/entity/Q93136500> ?p ?o ?g. }
Showing items 1 to 55 of
55
with 100 items per page.
- Q93136500 description "article scientifique publié en 2019" @default.
- Q93136500 description "artículu científicu espublizáu n'abril de 2019" @default.
- Q93136500 description "im April 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q93136500 description "scientific article published on 13 April 2019" @default.
- Q93136500 description "wetenschappelijk artikel" @default.
- Q93136500 description "наукова стаття, опублікована 13 квітня 2019" @default.
- Q93136500 name "SGLT2 inhibitor and incretin mimetic therapy for type 2 diabetes and chronic kidney disease" @default.
- Q93136500 name "SGLT2 inhibitor and incretin mimetic therapy for type 2 diabetes and chronic kidney disease" @default.
- Q93136500 type Item @default.
- Q93136500 label "SGLT2 inhibitor and incretin mimetic therapy for type 2 diabetes and chronic kidney disease" @default.
- Q93136500 label "SGLT2 inhibitor and incretin mimetic therapy for type 2 diabetes and chronic kidney disease" @default.
- Q93136500 prefLabel "SGLT2 inhibitor and incretin mimetic therapy for type 2 diabetes and chronic kidney disease" @default.
- Q93136500 prefLabel "SGLT2 inhibitor and incretin mimetic therapy for type 2 diabetes and chronic kidney disease" @default.
- Q93136500 P1433 Q93136500-9CCABE38-FFE8-49FC-AD21-B4828F3371B9 @default.
- Q93136500 P1476 Q93136500-82738438-B0C9-4BDF-8103-D00FF0465D38 @default.
- Q93136500 P2093 Q93136500-96BF1058-7B00-49C2-9C95-858E0ADE421C @default.
- Q93136500 P2860 Q93136500-17C17E5B-ECB8-438C-8D1B-3D12BF9D2D67 @default.
- Q93136500 P2860 Q93136500-1B84B7C7-5722-453B-963F-341691402BC4 @default.
- Q93136500 P2860 Q93136500-53AAA7A6-A76F-4255-8D64-2594368D1D87 @default.
- Q93136500 P2860 Q93136500-81A74B3D-A347-402D-91C6-386F30135C81 @default.
- Q93136500 P2860 Q93136500-8F791F35-8AEF-4D43-A62B-AFB84B93E137 @default.
- Q93136500 P2860 Q93136500-E5B95376-903A-46B9-AA52-D552CE2BE0D8 @default.
- Q93136500 P2860 Q93136500-F11FE49D-4640-4899-A8A0-9B524974FF46 @default.
- Q93136500 P2860 Q93136500-FE3B7D1D-B5E1-4A51-9360-A7C375716A6C @default.
- Q93136500 P304 Q93136500-61503652-0166-47E0-8C8E-B9C2A2968829 @default.
- Q93136500 P31 Q93136500-D08FD8D7-8C4E-49B3-8575-82438FC9B5BF @default.
- Q93136500 P356 Q93136500-B585217F-7AAD-4938-AA8D-843BE2AF7BC5 @default.
- Q93136500 P433 Q93136500-3F143047-0418-442B-A3F8-B072056BE172 @default.
- Q93136500 P478 Q93136500-EF8DF0BE-A04E-4031-B308-56D4DFAF558C @default.
- Q93136500 P577 Q93136500-DE11DB14-E63F-4F30-A693-9B2496160DEF @default.
- Q93136500 P698 Q93136500-C5C1DA9A-E8A2-42F8-8C8B-CE31E3727390 @default.
- Q93136500 P921 Q93136500-702AE23F-91F2-4627-823E-58FF2CEE9EAD @default.
- Q93136500 P921 Q93136500-D5E97CBA-92A0-4A21-B4A1-E978BADEFEC9 @default.
- Q93136500 P356 S2213-8587(19)30116-0 @default.
- Q93136500 P698 30992196 @default.
- Q93136500 P1433 Q27725107 @default.
- Q93136500 P1476 "SGLT2 inhibitor and incretin mimetic therapy for type 2 diabetes and chronic kidney disease" @default.
- Q93136500 P2093 "Katherine R Tuttle" @default.
- Q93136500 P2860 Q27012546 @default.
- Q93136500 P2860 Q34540403 @default.
- Q93136500 P2860 Q38729780 @default.
- Q93136500 P2860 Q40065123 @default.
- Q93136500 P2860 Q53084508 @default.
- Q93136500 P2860 Q89128962 @default.
- Q93136500 P2860 Q92980564 @default.
- Q93136500 P2860 Q93002242 @default.
- Q93136500 P304 "414-415" @default.
- Q93136500 P31 Q13442814 @default.
- Q93136500 P356 "10.1016/S2213-8587(19)30116-0" @default.
- Q93136500 P433 "6" @default.
- Q93136500 P478 "7" @default.
- Q93136500 P577 "2019-04-13T00:00:00Z" @default.
- Q93136500 P698 "30992196" @default.
- Q93136500 P921 Q3025883 @default.
- Q93136500 P921 Q736715 @default.